Since supraphysiological doses of CCK stimulate pancreatic insulin secretion, higher levels of circulating CCK induced by chronic palmitate treatment could be a compensatory response to insulin resistance in the prediabetic condition, which leads to hyperinsulinemia. Here, CCK is linked to hyperinsulinism.